- Home
- CMPX vs PSTL Comparison
CMPX vs PSTL Comparison
Compare CMPX & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- PSTL
- Stock Information
- Founded
- CMPX 2014
- PSTL 2018
- Country
- CMPX United States
- PSTL United States
- Employees
- CMPX N/A
- PSTL N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- PSTL Real Estate Investment Trusts
- Sector
- CMPX Health Care
- PSTL Real Estate
- Exchange
- CMPX Nasdaq
- PSTL Nasdaq
- Market Cap
- CMPX 291.8M
- PSTL 329.8M
- IPO Year
- CMPX N/A
- PSTL 2019
- Fundamental
- Price
- CMPX $2.97
- PSTL $14.56
- Analyst Decision
- CMPX Strong Buy
- PSTL Strong Buy
- Analyst Count
- CMPX 8
- PSTL 1
- Target Price
- CMPX $13.50
- PSTL $17.75
- AVG Volume (30 Days)
- CMPX 1.3M
- PSTL 135.5K
- Earning Date
- CMPX 08-11-2025
- PSTL 08-04-2025
- Dividend Yield
- CMPX N/A
- PSTL 6.66%
- EPS Growth
- CMPX N/A
- PSTL 344.13
- EPS
- CMPX N/A
- PSTL 0.39
- Revenue
- CMPX N/A
- PSTL $86,535,000.00
- Revenue This Year
- CMPX N/A
- PSTL $19.86
- Revenue Next Year
- CMPX N/A
- PSTL $10.14
- P/E Ratio
- CMPX N/A
- PSTL $37.61
- Revenue Growth
- CMPX N/A
- PSTL 26.43
- 52 Week Low
- CMPX $1.15
- PSTL $12.26
- 52 Week High
- CMPX $4.08
- PSTL $15.42
- Technical
- Relative Strength Index (RSI)
- CMPX 50.84
- PSTL 51.11
- Support Level
- CMPX $2.66
- PSTL $14.29
- Resistance Level
- CMPX $3.47
- PSTL $14.88
- Average True Range (ATR)
- CMPX 0.25
- PSTL 0.30
- MACD
- CMPX -0.02
- PSTL 0.04
- Stochastic Oscillator
- CMPX 38.27
- PSTL 75.19
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.